May 2020
AHFS Consumer Medication Information;May2020, p1
Acitretin is used to treat severe psoriasis (abnormal growth of skin cells that causes red, thickened, or scaly skin). Acitretin is in a class of medications called retinoids. The way acitretin works is not known.


Related Articles

  • Current therapeutic options in psoriasis. Boca, Andreea N.; Badalica-Petrescu, Marius; Buzoianu, Anca D. // Human & Veterinary Medicine;Apr2014, Vol. 6 Issue 1, p6 

    Psoriasis is a chronic inflammatory skin disorder, affecting the population worldwide. The exact etiology of the disease remains unknown, but there is a genetic predisposition, associated with a series of immunological determinants and predisposing environmental factors, which all lead to the...

  • National Psoriasis Foundation Speaks Out in Support Of New Psoriasis Drug. Gorgos, Diana // Dermatology Nursing;Oct2004, Vol. 16 Issue 5, p458 

    The article reports that the National Psoriasis Foundation Board of Trustees recently testified before the U.S. Food and Drug Administration in support of the drug oral tazarotene for treating moderate-to-severe psoriasis. The drug is a new vitamin A derivative, or retinoid, that selectively...

  • New oral psoriasis agents show promise. Jesitus, John // Dermatology Times;Sep2004 Supplement, Vol. 25, pS13 

    Introduces different oral treatment for psoriasis. Side effects of the retinoid, an oral tazarotene; Acquisition of a new oral formulation of the drug BG-12 oral fumarate by Biogen; Discussion on the effects of oral pimecrolimus on psoriatic patients.

  • Biologies for psoriasis pulling their weight. Wilson, Fred // Dermatology Times;Sep2004 Supplement, Vol. 25, pS18 

    The article discusses the effect of biologic therapy on psoriatic patients. Consideration of Amevive as the first biologic drug approved for moderate to severe plaque psoriasis; Elaboration on the effects of the drug, Raptiva; Responses of patients to Remicade infusions.

  • Practical considerations dog biologies. Jesitus, John // Dermatology Times;May2005, Vol. 26 Issue 5, p34 

    The article includes information on various treatment options available for curing psoriasis. It is reported that biologic treatments for psoriasis through the drugs clinically introduces a host of other concerns regarding drawbacks and safety profiles, not only for biologics, but also for many...

  • Flurandrenolide tape solves tough psoriatic lesions. Moyer, Paula // Dermatology Times;Dec98, Vol. 19 Issue 12, p10 

    Recommends the use of flurandrenolide tape in individuals with resistant psoriatic lesions. Comparison of response to flurandrenolide tape versus ointment and cream formulations; Percent of patients who exhibited improvements in sites treated with flurandrenolide; Low folliculitis rate; Side...

  • In vivo Study of Skin Mechanical Properties in Psoriasis Vulgaris. Dobrev, H. // Acta Dermato-Venereologica;09/20/2000, Vol. 80 Issue 4 

    The aim of this study was to investigate the mechanical properties of the skin in psoriatic plaques before and after treatment with dithranol and in clinically uninvolved psoriatic skin in comparison with the skin of healthy controls. In total, 82 psoriatic plaques in 19 in-patients and 51...

  • Systematic review of comparative efficacy and tolerability of calcipotriol in treating chronic plaque psoriasis. Ashcroft, Darren M.; Li Wan Po, Alain; Williams, Hywel C.; Griffiths, Christopher E.M. // BMJ: British Medical Journal (International Edition);04/08/2000, Vol. 320 Issue 7240, p963 

    Provides information on a study which evaluated the comparative efficacy and tolerability of topical calcipotriol in the treatment of mild to moderate chronic plaque psoriasis. Methods; Results and discussion; Conclusions.

  • Conservative Treatment Advised for Erythrodermic Psoriasis Patients. Kuznar, Wayne // Dermatology Times;May98, Vol. 19 Issue 5, p22 

    Focuses on the conservative therapy for erythrodermic psoriatic patients in the United States. Discussion on erythroderma; Differential diagnosis for psoriasis; Treatment.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics